EPI-326

· EpiBiologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EPI-326, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC [Phase 1]